Boston Scientific
Latest Boston Scientific News
-
Wearable devices track people via wireless network
medical device manufacturer Boston Scientific , have struck deals with major which makes the product. • Boston Scientific is updating its 6-year-old Stein, chief medical officer of Boston Scientific 's Cardiac Rhythm Management
-
CEOs receive big allowances on top of fat salaries
4 million from options and vested shares. Tyco, Boston Scientific and vitamin marketer GNC, among others, cut allowances alone. GNC raised salaries by up to $50,000. Boston Scientific , which gave $25,000 a year, doled out $75
-
CEOs pocket big allowances on top of fat salaries
4 million from options and vested shares. Tyco, Boston Scientific and vitamin marketer GNC, among others, cut allowances alone. GNC raised salaries by up to $50,000. Boston Scientific , which gave $25,000 a year, doled out $75
-
Top 10 U.S. Cities for Super Richsciences company Thermo Fisher Scientific, financial services company State Street Corp., medical device maker Boston Scientific and pharmaceutical company Genzyme. The cost of living is serious business in Boston, which has notoriously expensive
-
Doctors' groups welcome medical company dollars
including market leaders Medtronic, Boston Scientific and St. Jude Medical, which society's biggest funders — Boston Scientific and St. Jude Medical — have physicians about their devices. Boston Scientific declined to comment, and St
-
Medical groups sell companies access to their membership
including market leaders Medtronic, Boston Scientific and St. Jude Medical, which society's biggest funders — Boston Scientific and St. Jude Medical — have physicians about their devices. Boston Scientific declined to comment, and St
News
-
Stenting May Equal Bypass for Diabetic Heart Patients
of drug companies, including Eli Lilly & Co. and Bristol-Myers Squibb, as well as stent manufacturers such as Boston Scientific and Medtronic. For the study, a team led by Dr. Kevin J. Beatt from the Mayday University Hospital in London
-
Heart Device Might be Useless for Women
and 37.5 percent of patients who did not." Yet the gender question does not appear to be simple, according to Boston Scientific spokesperson, David Kinugson, who pointed out that a study recently published in the New England Journal of Medicine
-
Stenting a Good Option for Left Main Heart Artery
drugs to prevent clotting, made the procedure more feasible, he said. The SYNTAX study, sponsored by stent maker Boston Scientific Inc. and reported last year, found no difference in the mortality rate between people who had angioplasty and stent
-
Stocks higher on reports of CIT rescue
Investors are also focused on the next wave of earnings reports coming this week. On Monday, companies such as Boston Scientific BSX and Texas Instruments TXN are set to issue results. A string of good earnings news sent market indicators up
-
Possible HRT Link to Lung Cancer Death
study was supported by the NIH. The researchers reported financial links with Amgen, AstraZeneca, Eli Lilly, Novartis and Wyeth. Johnson reported financial links with Genzyme, Boston Scientific , Celgene, and Johnson and Johnson.
-
Drug-Coated Stents Better at Keeping Arteries Open
Swedish trial, which was funded by governmental and noncommercial organizations, the American trial was supported by Boston Scientific , which markets the Taxus stent. Again, the rate of re-stenosis was significantly lower in the group given a
-
High Rate of Early Heart Failure Seen in Blacks
University of California, San Francisco; Paul Underwood, M.D., medical director, interventional cardiology, Boston Scientific Corp ., Boston; Eric Peterson, M.D., M.P.H., associate professor, medicine, Duke Clinical Research Institute
